Ralph has led multiple peptide-based projects, and has extensive experience with unnatural antimicrobial peptides, conjugated peptides and macrocytes targeting intracellular peptidases. Ralph gained his PhD from the University of Liverpool before having various scientific leadership roles at CRUK, Charnwood Discovery and RedX.
